FDA Clears Lupin API Site Of NDMA Risk, Compliance Efforts Ongoing

 
• By Anju Ghangurde
  
Compliance
'SARTANS' MADE AT A LUPIN SITE HAVE BEEN DEEMED SAFE BY THE FDA

More from India

More from Asia